- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 6.44M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 6.16M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 6.16M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 6.08M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 6.07M sh |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $4.82M |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $19.39M |
| Capex | Q3 2025 · Sep 30, 2025 | $2.6M |
| Capex | Q3 2025 · Sep 30, 2024 | $3.2M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $5.48M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $10.14M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $5M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $5M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $9.21M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $8.93M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $17.06M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $18.86M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $162.06M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $163.68M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $163.56M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $165.92M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $165.99M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $165.83M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $164.37M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $170.55M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $18.38M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $16.56M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $56.3M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $55.8M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $50.33M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $47.09M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $218.35M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $221.73M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.08 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.15 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.20 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.35 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.08 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.15 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.20 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.35 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.82M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $9.06M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $2.9M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $8.99M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$532K |
| Net Income | Q3 2025 · Sep 30, 2025 | −$979K |
| Net Income | Q3 2025 · Jun 30, 2025 | $1.13M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$1.58M |
| Net Income | Q3 2025 · Sep 30, 2024 | $1.27M |
| Net Income | Q3 2025 · Sep 30, 2024 | $2.19M |
| Net Income | Q3 2025 · Jun 30, 2024 | $2.5M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$1.58M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$626K |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$1.52M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $1.65M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $1.37M |